Amanote Research
Register
Sign In
Cadherin-11 and Breast Cancer
doi 10.21236/ada407421
Full Text
Open PDF
Abstract
Available in
full text
Date
May 1, 2002
Authors
Stephen Byers
Publisher
Defense Technical Information Center
Related search
Cadherin-11 Expression Is Upregulated in Invasive Human Breast Cancer
Oncology Letters
Cancer Research
Oncology
Post-Transcriptional Regulation of Cadherin-11 Expression by GSK-3 and Β-Catenin in Prostate and Breast Cancer Cells
PLoS ONE
Multidisciplinary
E-Cadherin Polymorphisms and Breast Cancer Susceptibility: A Report From the Shanghai Breast Cancer Study
Breast Cancer Research and Treatment
Cancer Research
Oncology
E-Cadherin/Ros1 Inhibitor Synthetic Lethality in Breast Cancer
Cancer Discovery
Oncology
E-Cadherin as a Prognostic Indicator in Primary Breast Cancer
British Journal of Cancer
Cancer Research
Oncology
E-Cadherin Genetic Variants Predict Survival Outcome in Breast Cancer Patients
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
T‑cadherin Is Associated With Prognosis in Triple‑negative Breast Cancer
Oncology Letters
Cancer Research
Oncology
Prognostic Value of Lymphocyte Vascular Density and E-Cadherin in Inflammatory Breast Cancer
Journal of Cancer Therapy
Cytoplasmic P120ctn Regulates the Invasive Phenotypes of E-Cadherin-Deficient Breast Cancer
American Journal of Pathology
Forensic Medicine
Pathology